Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
6.02
+0.02 (0.33%)
At close: Dec 5, 2025, 4:00 PM EST
6.02
0.00 (0.00%)
After-hours: Dec 5, 2025, 6:43 PM EST
Coya Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Cash & Equivalents | 28.13 | 38.34 | 32.63 | 5.93 | 4.34 | 8.72 |
| Cash & Short-Term Investments | 28.13 | 38.34 | 32.63 | 5.93 | 4.34 | 8.72 |
| Cash Growth | -9.43% | 17.51% | 449.85% | 36.72% | -50.23% | - |
| Other Receivables | - | 0.73 | 7.5 | - | - | 0 |
| Receivables | - | 0.73 | 7.5 | - | - | 0 |
| Prepaid Expenses | 3.89 | 5.24 | 1.07 | 1.25 | 0.24 | 0.03 |
| Total Current Assets | 32.02 | 44.31 | 41.2 | 7.18 | 4.58 | 8.75 |
| Property, Plant & Equipment | 0.02 | 0.04 | 0.07 | 0.09 | 0.12 | - |
| Long-Term Deferred Charges | - | - | - | 1.12 | 0.09 | - |
| Accounts Payable | 1.11 | 1.59 | 1.16 | 1.82 | 0.86 | 0.45 |
| Accrued Expenses | 1.64 | 1.39 | 2.25 | 2.01 | 0.29 | - |
| Current Income Taxes Payable | - | - | 0.72 | - | - | - |
| Current Unearned Revenue | 0.92 | 0.85 | 0.92 | - | - | - |
| Total Current Liabilities | 3.67 | 3.82 | 5.05 | 3.82 | 1.15 | 0.45 |
| Long-Term Debt | - | - | - | 12.97 | - | - |
| Long-Term Unearned Revenue | 1.09 | 0.95 | 0.57 | - | - | - |
| Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 83.54 | 80.31 | 61.5 | 0.68 | 0.47 | 0.24 |
| Retained Earnings | -56.25 | -40.74 | -25.86 | -17.87 | -5.62 | -0.73 |
| Comprehensive Income & Other | - | - | -0.01 | - | - | - |
| Total Common Equity | 27.28 | 39.58 | 35.64 | -17.19 | -5.15 | -0.49 |
| Total Liabilities & Equity | 32.04 | 44.35 | 41.26 | 8.4 | 4.79 | 8.75 |
| Total Debt | - | - | - | 12.97 | - | - |
| Net Cash (Debt) | 28.13 | 38.34 | 32.63 | -7.03 | 4.34 | 8.72 |
| Net Cash Growth | -9.43% | 17.51% | - | - | -50.23% | - |
| Net Cash Per Share | 1.69 | 2.52 | 3.21 | -2.71 | 1.68 | 4.74 |
| Filing Date Shares Outstanding | 20.92 | 16.72 | 14.54 | 9.95 | 2.59 | 1.84 |
| Total Common Shares Outstanding | 16.74 | 16.71 | 14.41 | 2.59 | 2.59 | 1.84 |
| Working Capital | 28.36 | 40.48 | 36.14 | 3.36 | 3.44 | 8.3 |
| Book Value Per Share | 1.63 | 2.37 | 2.47 | -6.64 | -1.99 | -0.27 |
| Tangible Book Value | 27.28 | 39.58 | 35.64 | -17.19 | -5.15 | -0.49 |
| Tangible Book Value Per Share | 1.63 | 2.37 | 2.47 | -6.64 | -1.99 | -0.27 |
| Machinery | - | 0.14 | 0.14 | 0.14 | 0.14 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.